Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram pharmacogenetic study in major depression
ACTRN12609000295246Phase 4Completed
- Sponsor
- University of Tartu
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by University of Tartu. Primary endpoint: Montgomery-Asberg Depression Rating Scale remission and genotype association at week 12. Started Dec 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12609000295246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000295246.